Hims & Hers Health, Inc. Stock

Equities

HIMS

US4330001060

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-04-22 pm EDT 5-day change 1st Jan Change
11.88 USD -0.17% Intraday chart for Hims & Hers Health, Inc. -10.14% +33.48%
Sales 2024 * 1.19B Sales 2025 * 1.47B Capitalization 2.55B
Net income 2024 * 24M Net income 2025 * 52M EV / Sales 2024 * 1.95 x
Net cash position 2024 * 218M Net cash position 2025 * 382M EV / Sales 2025 * 1.48 x
P/E ratio 2024 *
156 x
P/E ratio 2025 *
53.1 x
Employees 1,046
Yield 2024 *
-
Yield 2025 *
-
Free-Float 83.01%
More Fundamentals * Assessed data
Dynamic Chart
Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 MT
Canaccord Genuity Initiates Coverage on Hims & Hers Health With Buy Rating, $20 Price Target MT
Hims & Hers Appoints Christopher Payne as Newest Board Member CI
Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $500,107, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $685,288, According to a Recent SEC Filing MT
Hims & Hers Health Insider Sold Shares Worth $5,032,142, According to a Recent SEC Filing MT
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating MT
Hims & Hers Health Shares Jump After Q4 Beat MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $11 From $9, Maintains Neutral Rating MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $14 From $8, Maintains Hold Rating MT
Truist Securities Adjusts Price Target on Hims & Hers Health to $13 From $10, Keeps Hold Rating MT
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; Hims & Hers Health Set to Gain, Intuitive Machines to Decline MT
Transcript : Hims & Hers Health, Inc., Q4 2023 Earnings Call, Feb 26, 2024
More news

Latest transcript on Hims & Hers Health, Inc.

1 day-0.17%
1 week-10.14%
Current month-23.21%
1 month-27.25%
3 months+36.71%
6 months+91.92%
Current year+33.48%
More quotes
1 week
11.59
Extreme 11.59
12.88
1 month
11.59
Extreme 11.59
17.16
Current year
8.09
Extreme 8.09
17.16
1 year
5.65
Extreme 5.65
17.16
3 years
2.72
Extreme 2.72
17.16
5 years
2.72
Extreme 2.72
25.40
10 years
2.72
Extreme 2.72
25.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 35 21-01-19
Director of Finance/CFO 57 22-01-23
Chief Tech/Sci/R&D Officer 66 18-12-31
Members of the board TitleAgeSince
Director/Board Member 82 21-01-19
Director/Board Member 41 17-09-30
Director/Board Member 49 21-01-19
More insiders
Date Price Change Volume
24-04-22 11.88 -0.17% 3,450,437
24-04-19 11.9 -3.57% 4,828,326
24-04-18 12.34 -0.56% 3,549,539
24-04-17 12.41 -2.21% 3,898,714
24-04-16 12.69 -4.01% 7,022,686

Delayed Quote Nyse, April 22, 2024 at 04:00 pm EDT

More quotes
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. The Company’s digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The Company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
11.9 USD
Average target price
14.94 USD
Spread / Average Target
+25.57%
Consensus